GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (MEX:RMD) » Definitions » ROE % Adjusted to Book Value

ResMed (MEX:RMD) ROE % Adjusted to Book Value : 4.66% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is ResMed ROE % Adjusted to Book Value?

ResMed's ROE % for the quarter that ended in Sep. 2024 was 25.62%. ResMed's PB Ratio for the quarter that ended in Sep. 2024 was 5.50. ResMed's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 4.66%.


ResMed ROE % Adjusted to Book Value Historical Data

The historical data trend for ResMed's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed ROE % Adjusted to Book Value Chart

ResMed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.24 1.40 2.79 2.67 3.64

ResMed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.65 3.66 4.12 4.01 4.66

Competitive Comparison of ResMed's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, ResMed's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ResMed's ROE % Adjusted to Book Value falls into.



ResMed ROE % Adjusted to Book Value Calculation

ResMed's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=23.39% / 6.43
=3.64%

ResMed's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=25.62% / 5.50
=4.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ResMed ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ResMed's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ResMed Business Description

Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.